ePrints

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Lookup NU author(s): Helen MossopORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Wilkins A, Mossop H, Syndikus I, Khoo V, Bloomfield D, Parker C, Logue J, Scrase C, Patterson H, Birtle A, Staffurth J, Malik Z, Panades M, Eswar C, Graham J, Russell M, Kirkbride P, O'Sullivan JM, Gao A, Cruickshank C, Griffin C, Dearnaley D, Hall E

Publication type: Article

Publication status: Published

Journal: Lancet Oncology

Year: 2015

Volume: 16

Issue: 16

Pages: 1605-1616

Print publication date: 01/12/2015

Online publication date: 27/05/2015

Acceptance date: 01/01/1900

ISSN (print): 1470-2045

ISSN (electronic): 1474-5488

Publisher: The Lancet Publishing Group

URL: http://dx.doi.org/10.1016/S1470-2045(15)00280-6

DOI: 10.1016/S1470-2045(15)00280-6

Altmetrics

Share